Use of a Vaginal Ring Containing Dapivirine for HIV-1 Prevention in Women

Published in the New England Journal of Medicine on December 1, 2016, this article reports on the results of A Study to Prevent Infection with a Ring for Extended Use (ASPIRE). The authors conclude that a monthly vaginal ring containing dapivirine reduced the risk of HIV-1 infection among African women, with increased efficacy among subgroups of the study population with evidence of more consistent use of the ring.

Length: 
12 pages
Year: 
2016
Organization: 
Microbicide Trials Network
Languages: 
English
Author(s): 
Baeten JR, Palanee-Phillips T, Brown ER, Schwartz K, et al.